Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 69, Issue 1, 2000, Pages 25-28

  Fazekas, Franz ^a   Strasser Fuchs, Siegrid ^a   Schmidt, Helena ^b   Enzinger, Christian ^a   Ropele, Stefan ^a   Lechner, Anita ^a   Flooh, Erich ^a   Schmidt, Reinhold ^a   Hartung, Hans Peter ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b Institute of Medical Biochemistry   (Austria)

Author keywords

Apolipoprotein E genotype; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

APOLIPOPROTEIN E;

ADOLESCENT; ADULT; ARTICLE; BRAIN INJURY; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TISSUE REPAIR;

EID: 0034124139     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.69.1.25     Document Type: Article

References (24)

1. Poser C. The epidemiology of multiple sclerosis. A general overview. Ann Neurol 1994;36(suppl 2):S180-93.
2. Sadovnick AD, Ebers GC, Dyment DA, et al. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996;347:1728-30.
3. Sawcer S, Goodfellow PN, Compston A. The genetic analysis of multiple sclerosis. Trends Genet 1997;13:234-9.
4. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. I: Clinical course and disability. Brain 1989;112:113-46.
5. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-11.
6. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30.
7. Nathan BP, Bellosta S, Sanan DA, et al. Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science 1994;264:850-2.
8. Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelinisation of the rat sciatic nerve. J Clin Invest 1989;83:1015-31.
9. Evangelou N, Jackson M, Beeson D, et al. Association of the APOE ε4 allele with disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999;67:203-5.
10. Høgh P, Blinkenberg M, Jørgensen OS, et al. Apolipoprotein E (APOE) and multiple sclerosis: impact of the epsilon-4 allele on suceptibility, clinical type and progression rate [abstract]. Eur J Neurol 1998;5(suppl 3):121.
11. Miller DH, Grossman RI, Reingold SC, et al. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24.
12. van Walderveen MAA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR / short-TE (T1-weighted) spin-echo images. Neurology 1995;45:1684-90.
13. Brück W, Bitsch A, Kolenda H, et al. Inflammatory central nervous system demyelination. Correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-93.
14. van Walderveen MAA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-8.
15. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
16. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
17. Rovaris M, Filippi M, Calori G, et al. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 1997; 244:266-70.
18. Filippi M, Gawne-Cain ML, Gasperini C, et al. Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis. Neurology 1998;50:238-44.
19. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-8.
20. Rubinsztein DC, Hanlon CS, Irving RM, et al. Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol Cell Probes 1994;8:519-25.
21. Gervais A, Gaillard O, Plassart E, et al. Apolipoprotein E polymorphism in multiple sclerosis. Ann Clin Biochem 1998;35:135-6.
22. Weatherby SJM, Mann CLA, Davies MB, et al. Polymorphisms of apolipoprotein E: outcome and susceptibility of multiple sclerosis. Mult Scler 2000;6:32-6.
23. 1-hypointense multiple sclerosis lesions demonstrated in two using proton magnetic resonance spectroscopy. Ann Neurol 1999;46:79-87.
24. Chapman J, Sylantiev C, Nisipeanu P, et al. Preliminary observations on APOE ε4 allele and progression of disability in multiple sclerosis. Arch Neurol 1999;56:1484-7.